SGYP Shares Outstanding History



Below is a table of the SGYP shares outstanding history going back to 12/1/2011:

Date SGYP Shares Outstanding
12/1/201148.99M
3/13/201255.07M
5/9/201265.21M
8/8/201266.73M
11/12/201267.03M
3/15/201374.42M
5/8/201391.44M
8/8/201391.44M
11/8/201391.44M
3/16/201493.57M
5/9/201493.70M
8/11/201494.80M
11/10/201496.61M
3/16/201596.61M
5/8/2015100.05M
11/4/2015113.67M
2/25/2016113.69M
5/10/2016179.78M
8/5/2016179.45M
11/7/2016179.95M
3/1/2017223.12M
5/10/2017224.95M
8/9/2017224.95M
11/9/2017224.95M
3/1/2018246.66M
5/10/2018246.74M
8/8/2018247.99M
11/9/2018248.04M

Also see: SGYP Market Cap History
SGYP YTD Return
SGYP Historical Shares Outstanding:
+26.31% CAGR
SGYP Historical Shares Outstanding: +26.31% CAGR

Mouse over chart for data details
12/1/2011 ...11/9/2018
Synergy Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. Co. is engaged in the discovery, research and development activities around analogs of uroguanylin, a naturally occurring and endogenous human GI peptide, for the treatment of GI diseases and disorders. Co. discovered, is developing and controls 100% worldwide rights to its proprietary uroguanylin analog platform. Co.'s commercial product, plecanatide, under trademark name TRULANCE™ is for the treatment of adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. We show 28 historical shares outstanding datapoints in our coverage of SGYP's shares outstanding history.

Understanding the changing numbers of SGYP shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SGYP versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SGYP by allowing them to research SGYP shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree SGYP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Synergy Pharmaceuticals (SGYP) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

SHC Shares Outstanding History
SHOT Shares Outstanding History
SHPH Shares Outstanding History
SIBN Shares Outstanding History
SIEN Shares Outstanding History
SIGA Shares Outstanding History
SILK Shares Outstanding History
SINT Shares Outstanding History
SIOX Shares Outstanding History
SKIN Shares Outstanding History
More Healthcare companies »

 

SGYP Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.